Allergan Inc.

NYS : AGN
Pharmaceuticals
Irvine California
2011 Revenue (US$ Millions)$5,419
2010 Revenue (US$ Millions)$4,919
Revenue Growth (%)10.16%
Net Income (US$ Millions)$935
Common Shares Outstanding (Millions)$305
Earnings Per Share (US$)$3.01
Earnings Per Share Growth (%)N/A
Price To Earnings Ratio28.99
Total Equity (US$ Millions)$5,310
Profit Growth (%)155650
Profit Margin (%)17.24%
Return On Equity (%)19.64%
Long Term Debt (US$ Millions)$1,515
Debt To Equity Ratio (%)0.29%
Market Capitalization (US$ Millions)$26,785
Total Assets (US$ Millions)$8,509
Return on Assets (%)11.25
Current Assets (US$ Millions)$4,048
Inventories (US$ Millions)$250
Current Liabilities (US$ Millions)$955
Cost of Goods Sold (US$ Millions)$749
Asset Turnover0.64
Inventory Turnover3.13